We suggest that there is a positive feedback loop in response to cholesterol and its metabolites in breast cancer cells, and this loop involves increased tyrosine kinase receptor phosphorylation and ER activation, with subsequent nuclear translocation, where they upregulate target genes (including IGF-I, IGF-IR, and EGFR). Here, ESR1 is linked to breast carcinoma.